← All diseases
Cancer
Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma. (2024/09/18) ♡
- Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myeloma. (2024/09/16) ♡
- Prognostic value of the Controlling Nutritional Status score in patients with newly diagnosed multiple myeloma. (2024/09/15) ♡
- Efficacy of nebulized GM-CSF inhalation in preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation: A retrospective study. (2024/09/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple Myeloma Presenting as Hypercalcemia-Induced Acute Severe Pancreatitis: A Case Report. (2024/09/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Seamless Navigation of Bispecific Therapies: Optimizing Management and Outpatient Access With a Focus on Coordination. (2024/09/11) ♡
- Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. (2024/09/01) ♡
- The Impact of Focal Lesions on Overall and Progression-free Survival in Multiple Myeloma. (2024/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients. (2024/08/06) ♡
- Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity. (2024/08/01) ♡
- Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis. (2024/08/01) ♡
- CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies. (2024/07/31) ♡
- The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations. (2024/07/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action. (2024/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple myeloma with secondary amyloidosis: Dysphagia as the first symptom: A case report. (2024/07/12) ♡
- Gastrointestinal toxicities of proteasome inhibitor therapy. (2024/07/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy. (2024/07/02) ♡
- Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution. (2024/07/02) ♡
- Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy. (2024/07/01) ♡
- Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross-sectional study. (2024/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials. (2024/07/01) ♡
- Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer. (2024/06/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interleukin-6 serves as a critical factor in various cancer progression and therapy. (2024/06/20) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Regarding the prognostic role of vitamin D deficiency in a Japanese multiple myeloma study. (2024/06/18) ♡
- Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study. (2024/06/14) ♡
- Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma. (2024/06/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple Myeloma With Idiopathic Intracranial Hypertension. (2024/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Strategic testing following toxic epidermal necrolysis allows reintroduction of chemotherapy in a patient with progressive myeloma. (2024/06/01) ♡
- Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies. (2024/06/01) ♡
- Circulating miR-16 and miR-21 Levels in Multiple Myeloma: Prognostic Significance of Survival and Response to Lenalidomide Treatment. (2024/05/31) ♡
- The Impact of a 6-Week Nordic Walking Training Cycle and a 14-Hour Intermittent Fasting on Disease Activity Markers and Serum Levels of Wnt Pathway-Associated Proteins in Patients with Multiple Myeloma. (2024/05/08) ♡
- Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx. (2024/05/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature. (2024/05/01) ♡
- Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab. (2024/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beneficial Effect of Olive Oil and Its Derivates: Focus on Hematological Neoplasm. (2024/04/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Maximum serum K+ concentration within 1 hour with enteral replacement in severe hypokalemia. (2024/04/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review. (2024/04/24) ♡
- Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis. (2024/04/21) ♡
- Development and Implementation of an eHealth Oncohematonootric Program: Descriptive, Observational, Prospective Cohort Pilot Study. (2024/04/08) ♡
- Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study. (2024/04/01) ♡
- Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study. (2024/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case of angioimmunoblastic T-cell lymphoma presenting as peripheral and bone marrow plasmacytosis: A diagnostic conundrum. (2024/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hypergranular multiple myeloma with crystalline inclusions in young with 13q deletion. (2024/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synchronous multiple myeloma and lung adenocarcinoma: A clinical series. (2024/04/01) ♡
- Urinary Insulin-Like Growth Factor-Binding Protein 7 (IGFBp7), Urinary Tissue Inhibitor of Matrix Metalloproteinase 2 (TIMP2), and Serum Transgelin as Novel Biomarkers of Kidney Injury in Multiple Myeloma. (2024/04/01) ♡
- [Effects of Different Nutritional Scoring Systems on Prognosis of Elderly Patients with Multiple Myeloma]. (2024/04/01) ♡
- IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients. (2024/03/24) ♡
- Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system. (2024/03/13) ♡
- Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology. (2024/03/12) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.